Dr Reddy's Q2 net profit falls 36% to Rs 925 crore
FROM THE WIRE · THEHINDUBUSINESSLINE.COM
Revenue dips 1.5%; results hit by ₹239 crore provision related to Semaglutide API
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishA quarterly profit drop caused by a semaglutide API provision weighs on results.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Revenue dipped 1.5%.
- 02Results were hit by a Rs 239 crore provision related to Semaglutide API.
- 03Q2 net profit fell 36% to Rs 925 crore.